N. Lima et al., LEVOTHYROXINE SUPPRESSIVE THERAPY IS PARTIALLY EFFECTIVE IN TREATING PATIENTS WITH BENIGN, SOLID THYROID-NODULES AND MULTINODULAR GOITERS, Thyroid, 7(5), 1997, pp. 691-697
We prospectively evaluated the effect of thyrotropin (TSH)-suppressive
therapy with levothyroxine (LT4) on the size of a benign, solitary, s
olid nodule and multinodular goiter in a relatively low iodine intake
area. In this study, 101 euthyroid subjects with a benign, solitary, p
redominantly solid nodule (n = 54) confirmed by biopsy or multinodular
goiter (n = 47) received 200 mu g of levothyroxine daily as a single
morning tablet for 12 months. Thirty-five receiving no therapy were co
nsidered as controls (solitary nodules, n = 20, multinodular, n = 15).
Patients were admitted to the study after evaluation of thyroid bioch
emical parameters (thyroxine [T-4], free thyroxine [FT4], triiodothyro
nine [T-3], thyrotropin [TSH], and thyroglobulin [Tg]), thyroid scanni
ng, ultrasound examination, and fine-needle aspiration biopsy. Every 3
months, thyroid function tests and every 6 months ultrasound examinat
ions were repeated. Twelve months later 20 of 54 (37.1%) patients with
single, solid nodules had 50% or more regression of the nodular volum
e (responders). Eleven of 54 (20.3%) patients had more than 20%, but l
ess than 49.9% reduction of nodular volume (partial responders). Nonre
sponders were 23 of 54 (42.5%). One-third of subjects with multinodula
r goiter had 50% or more regression of the glandular volume, whereas 4
6.8% were considered as nonresponsive. The mean serum Tg levels decrea
sed significantly only in responders with solitary nodular disease or
multinodular goiter. In the control group only 1 patient (5% of total)
with a solitary nodule had a 50% reduction in the nodular volume. Fiv
e others had a partial response (<49%, >20% reduction). None of the pa
tients with multinodular goiter had a significant reduction (>50%) of
the combined nodular volumes. We concluded that LT4 may be effective,
among other factors, in arresting the growth or in reducing the volume
of relatively small, benign, solitary, solid thyroid nodules or the c
ombined nodular volume of multinodular goiter.